1358 — PW Medtech Income Statement
0.000.00%
Last trade - 00:00- HK$1.52bn
- HK$620.38m
- CNY768.90m
- 61
- 91
- 74
- 90
Annual income statement for PW Medtech, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | HKAS | HKAS | HKAS | HKAS | HKAS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 247 | 271 | 537 | 675 | 769 |
| Cost of Revenue | |||||
| Gross Profit | 149 | 166 | 299 | 381 | 419 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | -271 | -409 | 414 | 488 | 589 |
| Operating Profit | 518 | 681 | 123 | 187 | 179 |
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | 627 | 737 | 158 | 231 | 230 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 632 | 739 | 129 | 205 | 193 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | 632 | 739 | 106 | 153 | 151 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 632 | 739 | 106 | 153 | 151 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.418 | 0.185 | 0.074 | 0.102 | 0.098 |
| Dividends per Share | |||||
| Special Dividends per Share |